Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 7Observational 2

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Uterine Cervical Neoplasms 7Uterine Cervical Dysplasia 3Papillomavirus Infections 2Uterine Cervical Diseases 1Squamous Intraepithelial Lesions 1Precancerous Conditions 1Acquired Immunodeficiency Syndrome 1

Interventions

Data Collection 9human papillomavirus vaccine, L1 type 16, 18 4Blood Specimen Collection 4Surveys and Questionnaires 3Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3Specimen Handling 2Polymerase Chain Reaction 2Papillomavirus Vaccines 2Observation 2Colposcopy 2Viral Load 1Vaginal Smears 1Vaccination 1Restraint, Physical 1Papanicolaou Test 1Methods 1Mass Screening 1Liquid Biopsy 1Interviews as Topic 1Independent Medical Evaluation 1Human Papillomavirus Recombinant Vaccine nonavalent 1Human Papillomavirus DNA Tests 1Histological Techniques 1High-Energy Shock Waves 1Gene Expression Profiling 1Focus Groups 1Flow Cytometry 1Early Intervention, Educational 1Cytological Techniques 1Cryotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Papillomavirus Infections × Colposcopy × Clear all
NCT02634190 2024-02-28

Clinical Evaluation of the APTIMA® HPV Assay and Comparison With the HR HC2® Test Using LBC ThinPrep® Specimens

Hologic Deutschland GmbH

Completed
10,000 enrolled

Papillomavirus Infections

NCT00977392 2013-08-07

Self-Sampling in Women Who Do Not Undergo Routine Cervical Screening

National Cancer Institute (NCI)

Completed
3,000 enrolled
Other neoplasm

Precancerous Conditions, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡